ArtisanBio provides premiere genome engineering tools for cell and gene therapy companies looking for an accelerated path to clinic with reduced development costs. Offerings include a commercial-scale STAR-CRISPR editing system, optimized guide and data packages, and a pre-built cell therapy allogeneic chassis. Artisan’s genome engineering platform enables gene editing at competitive knock out and knock in efficiencies across a variety of cell types such as primary T-cells and iPSCs. Artisan also partners with companies for custom genome engineering, including novel target knockouts, dual-CAR sized payload inserts, CAR design optimization, and multiplexed editing optimization. With experience collaborating with global pharma partners to private biotechs, Artisan delivers genome engineering tools with broad non-exclusive licenses.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Colorado
Company HQ Country:
United States
Year Founded:
2018
Main Therapeutic Focus:
Gene/Cell Therapy
Lead Product in Development:
Stealth Allogeneic Pan-Solid Tumor CAR-T
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
